James Allison of the United States and Tasuku Honjo of Japan were awarded the 2018 Nobel Prize in Physiology or Medicine for their contributions to the discovery of negative immune regulation, also known as CTLA4 and PD-1, as cancer treatments (82). Here, CTLA4 is linked to cancer.